What other organisms are classified as Carbapenem-Resistant Enterobacteriaceae (CRE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Organisms Classified as Carbapenem-Resistant Enterobacteriaceae (CRE)

Klebsiella pneumoniae and Escherichia coli are the predominant organisms classified as CRE, with K. pneumoniae accounting for 53-77% of all CRE isolates and representing the most frequently recovered CRE species in U.S. healthcare settings. 1

Primary CRE Species

Klebsiella pneumoniae is the dominant CRE organism:

  • Represents approximately 53-77% of all CRE isolates in surveillance studies 1
  • Carbapenem-resistant K. pneumoniae (CRKP) is the most commonly encountered CRE species in the United States 2
  • Prevalence increased dramatically from <1% of all Klebsiella isolates in 2000 to 8% by 2007 1

Escherichia coli is the second major CRE organism:

  • CDC and HICPAC guidelines specifically target both Klebsiella species and E. coli for active surveillance cultures because these two organisms represent the majority of CRE encountered in the United States 1
  • These organisms can be detected without molecular methods, making them practical surveillance targets 3

Other Enterobacteriaceae Species

While the guidelines emphasize K. pneumoniae and E. coli, CRE encompasses all members of the Enterobacteriaceae family that demonstrate resistance to carbapenems (doripenem, imipenem, or meropenem) 2. This broader family includes:

  • Other Klebsiella species beyond K. pneumoniae 3
  • Additional Enterobacteriaceae genera that can acquire carbapenem resistance through carbapenemase production or other mechanisms 3

Clinical Surveillance Rationale

The focused surveillance on Klebsiella spp. and E. coli is strategically justified because:

  • These two species constitute the vast majority of clinically significant CRE infections 3, 1
  • Detection methods for these organisms are more readily available in standard microbiology laboratories 1
  • Carbapenemase genes are carried on mobile genetic elements (plasmids and transposons), allowing rapid dissemination between bacterial species 2

Resistance Mechanism Classification

All CRE organisms share carbapenem resistance but differ in mechanisms:

  • Carbapenemase-producing Enterobacteriaceae (CPE) produce enzymes (KPC, NDM, VIM, IMP, OXA-48-like) that hydrolyze carbapenems 3
  • Non-CPE CRE achieve resistance through other mechanisms such as porin loss 3, 2
  • The term "CPE" is more precise than "CRE" when carbapenemase production is confirmed 2

References

Guideline

Carbapenem-Resistant Enterobacteriaceae Epidemiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Carbapenem-Resistant Enterobacteriaceae Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.